PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
for
Pancreatic Cancer
Location: Milwaukee WI, Scottsdale AZ
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04683315
Phase2, Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
for
Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Providence RI, New York NY, Charleston SC,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT04429542
Phase1, Recruiting
Interested in new pancreatic cancer trials?
Get alerts for new trials in your area by subscribing now
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors